Patient-led NHS revolution to continue, says under fire Hewitt
January 18, 2006Patricia Hewitt has pledged to press ahead with the next phase of Labour's NHS reforms, despite renewed opposition from within …
Merck in race to bring first cervical cancer vaccine to market
January 18, 2006Sales and Marketing
Merck and GlaxoSmithKline are head-to-head in a race to establish a market for their rival cervical cancer vaccines, both set …
Drinking straw a novel antibiotic delivery for children
January 17, 2006Sales and Marketing
A new drinking straw that administers antibiotics to children as they drink has been launched by German pharma company Grunenthal.Clarosip …
Virgo Health wins Cymbalta account
January 17, 2006Medical Communications
Virgo Health has been appointed to promote depression brand Cymbalta to healthcare professionals in the UK following a two-way competitive …
Right time, right place, right patient
January 17, 2006Research and Development
With patient recruitment such a key cog in the overall clinical trial machine, pharma and biotech businesses are increasing their …
Pfizer to go it alone with Exubera
January 16, 2006Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin
Pfizer has paid $1.3 billion to buy out its marketing partner’s stake in new inhaled diabetes drug Exubera.The US company …
Gene discovery offers new diabetes drug target hope
January 16, 2006Research and Development
A gene thought to be present in around 20% of type II diabetes patients has been identified, opening up the …
Unfamiliar territory
January 13, 2006At this year's NHS Confederation conference in June, the most debated corridor question was whether or not there would be …
Patients unaware as flagship NHS choice scheme launched
January 12, 2006Primary Care Trusts across England have launched an unprecedented marketing campaign to promote the new NHS choice agenda to patients.From …
Packer Forbes wins Remicade and Altana accounts
January 12, 2006Medical Communications
Packer Forbes has won new accounts from Schering-Plough for the arthritis treatment Remicade and from Altana Pharma for the company's …
Bayer buys hypertension drug rights from GSK
January 12, 2006Sales and Marketing
Bayer has bought the rights to market the hypertension drug telmisartan in a number of European markets from current licence …
Action needed on prostate cancer services
January 12, 2006Patients with prostate cancer are a lower NHS priority than those with other major cancers, despite the disease's status as …
PCT merger plans ‘ill conceived’
January 12, 2006Government plans for a radical restructuring of the NHS have been condemned in a new report by a committee of …
New dawn or beginning of the end? Medicare D comes of age
January 12, 2006Sales and Marketing
Millions of Americans woke up on 1 January 2006 and found themselves in an unfamiliar position having their prescription medicine …
GlaxoSmithKline considering Serono acquisition
January 12, 2006Sales and Marketing
GlaxoSmithKline is understood to be considering the acquisition of Europe's biggest biotech company Serono, currently worth around $12 billion.Serono's chief …
Wanted: Innovative drugs
January 12, 2006Research and Development prix galien
When the UK government last month announced a series of measures to boost research and development in the NHS, its …
Programme exposes counterfeit dangers
January 12, 2006Manufacturing and Production
An undercover investigation by a TV documentary team has uncovered serious flaws in the policing of UK pharmaceutical wholesaling and …
AstraZeneca buys UK cancer research firm
January 4, 2006Research and Development
AstraZeneca has bought a small UK biotech company KuDOS which specialises in cutting edge cancer research.AstraZeneca made its name in …
Woman wins right to Herceptin trial
December 22, 2005A woman with breast cancer has been granted the right to take her PCT to court for barring access to …
Politics and Healthcare – still a volatile mix
December 22, 2005Politics and the provision of healthcare are, it is generally agreed, ultimately inseparable; but their frequent interactions are a continual …
Latest content
FibroFind appoints Lee Borthwick as CEO
